Cannabinoid Science and UK Health Education
THC vs CBD: Key Differences, Effects, Benefits, Risks and UK Laws
A comprehensive educational comparison of tetrahydrocannabinol (THC) and cannabidiol (CBD), covering their chemical properties, effects on the endocannabinoid system, medical research, potential adverse effects and legal status in the United Kingdom.
Updated: October 2026
What Are THC and CBD?
THC and CBD are two of the best-known cannabinoids associated with the cannabis plant. Although they are often mentioned together, they differ in their effects on the nervous system, potential medical applications and legal treatment.
THC stands for tetrahydrocannabinol. The form most commonly discussed is delta-9- tetrahydrocannabinol, often shortened to delta-9 THC.
CBD stands for cannabidiol. It is another naturally occurring cannabinoid that has received substantial scientific attention.
Both substances interact with biological systems, but they do not produce identical effects. In particular, THC can cause intoxication, whereas CBD does not typically cause the same intoxicating experience.
Understanding this difference is essential when interpreting research findings, legal guidance and health claims.
What Is THC?
Tetrahydrocannabinol is a psychoactive cannabinoid found in cannabis.
THC interacts with cannabinoid receptors in the nervous system and can influence memory, attention, coordination, perception and judgement.
Its intoxicating properties distinguish it from many other cannabinoids.
THC has also been studied in medical research, including investigations involving specific prescription cannabinoid medicines.
However, the existence of medical research does not establish that ordinary commercial THC products are approved medicines.
For additional scientific context, see the related educational article Delta-9 THC: Scientific and Legal Overview.
What Is CBD?
Cannabidiol is a cannabinoid that differs from THC in its interactions with the nervous system.
CBD does not typically produce the same intoxicating effects associated with THC.
Nevertheless, CBD is pharmacologically active and should not be treated as biologically inert.
Research has investigated CBD in relation to several medical conditions. Certain purified cannabidiol medicines have demonstrated benefits for specific severe epilepsy syndromes.
These findings apply to particular pharmaceutical preparations and clinical circumstances. They do not demonstrate equivalent effectiveness for all CBD-containing products.
THC vs CBD: Complete Comparison
| Feature | THC | CBD |
|---|---|---|
| Full name | Tetrahydrocannabinol | Cannabidiol |
| Chemical formula | C21H30O2 | C21H30O2 |
| Intoxicating effects | Can cause intoxication | Not typically intoxicating |
| CB1 receptor interaction | Acts as a partial agonist | Has a more complex and indirect pharmacological profile |
| Effects on cognition | Can impair memory, attention and coordination | Does not typically cause THC-like impairment |
| UK drug-control status | Controlled cannabinoid | Pure CBD is not itself controlled |
| Medical evidence | Evidence for certain specific medicines and indications | Evidence for certain prescription epilepsy treatments |
| Potential risks | Intoxication, cognitive effects, psychological effects and dependence | Side effects, interactions and possible liver-related concerns |
| Regulatory considerations | Controlled-drug and medicines legislation | Product composition, medicines and food regulations may apply |
Why Do THC and CBD Have the Same Molecular Formula?
THC and CBD share the molecular formula C21H30O2, but their atoms are arranged differently.
Compounds that share a molecular formula while differing in structural arrangement are known as structural isomers.
Molecular structure influences how a substance interacts with biological targets.
Therefore, having the same molecular formula does not mean that THC and CBD have identical properties.
This distinction helps explain why closely related cannabinoids can produce different effects in the human body.
Understanding the Endocannabinoid System
The endocannabinoid system is a biological signalling network involved in regulating several physiological processes.
It includes naturally occurring signalling molecules called endocannabinoids, cannabinoid receptors and enzymes involved in endocannabinoid metabolism.
The system contributes to processes associated with appetite, memory, movement, pain signalling and other functions.
CB1 Receptors
CB1 receptors are found throughout parts of the central nervous system.
THC interacts with these receptors, contributing to its psychoactive effects.
CB2 Receptors
CB2 receptors are associated with immune signalling, although the distribution and functions of cannabinoid receptors are complex.
How THC Interacts With Receptors
THC acts as a partial agonist at cannabinoid receptors.
This means it can activate receptors, but its activity differs from that of a full receptor agonist.
Its activity at CB1 receptors is especially relevant to its intoxicating effects.
How CBD Differs
CBD has a more complex pharmacological profile.
Its effects cannot be explained simply as direct activation of CB1 receptors.
Researchers continue to investigate its interactions with several molecular targets and signalling pathways.
THC vs CBD: Effects on the Brain
One of the clearest differences between THC and CBD concerns intoxication and cognitive effects.
THC and Cognitive Function
THC can impair attention, working memory, coordination and reaction time.
These effects may interfere with learning, decision-making and activities requiring concentration.
CBD and Cognitive Function
CBD does not typically cause the same intoxicating effects.
However, some CBD medicines can cause drowsiness and other adverse effects.
The absence of THC-like intoxication does not establish that CBD is free from safety concerns.
THC vs CBD and Mental Health
Mental health is an important consideration in cannabinoid research.
THC can cause anxiety, confusion and unwanted changes in perception.
Regular cannabis exposure is associated with increased risk of psychotic illness in some individuals.
CBD is being investigated in several areas of mental-health research, but evidence remains insufficient to support broad treatment claims.
Neither cannabinoid should be presented as a universal treatment for psychological conditions.
THC vs CBD and Dependence
Repeated exposure to THC-containing cannabis can contribute to dependence in some people.
Dependence may involve difficulty stopping use despite negative effects on everyday life.
CBD does not have the same established pattern of intoxicating effects, but that does not remove the need for appropriate medical supervision when CBD is used as a prescription medicine.
THC vs CBD and Young People
Young people require particular protection from the risks of psychoactive cannabinoids.
The brain continues developing throughout adolescence.
THC exposure during this period raises concerns about memory, attention, learning and mental health.
Prescription cannabinoid medicines may sometimes be appropriate for particular paediatric conditions, but these decisions require specialist clinical care.
THC vs CBD and Pregnancy
Cannabis exposure during pregnancy and breastfeeding raises important concerns.
Evidence about the safety of many cannabinoid preparations remains incomplete.
Pregnant or breastfeeding patients should discuss cannabinoid medicines with their healthcare professionals rather than relying on commercial health claims.
Potential Side Effects
| Potential Effect | THC | CBD |
|---|---|---|
| Drowsiness | Possible | Possible |
| Dizziness | Possible | Possible |
| Intoxication | Established | Not typical |
| Impaired coordination | Possible | Not typically THC-like |
| Anxiety or distress | Possible | Effects vary; not an established general treatment |
| Medicine interactions | Possible | Possible |
| Liver-related concerns | Depends on clinical circumstances | Relevant to certain prescription CBD medicines |
THC vs CBD in Medical Research
Cannabinoids have been investigated for several medical conditions.
However, evidence varies considerably between individual compounds, pharmaceutical preparations and clinical indications.
A research finding involving a regulated medicine cannot automatically be applied to every product containing the same cannabinoid.
CBD and Epilepsy
One of the most established medical applications of cannabidiol involves specific severe epilepsy syndromes.
Epidyolex is a prescription cannabidiol medicine used under defined clinical conditions.
It is not equivalent to ordinary commercial CBD products.
Specialist assessment and monitoring are important parts of treatment.
THC and Multiple Sclerosis
Certain cannabinoid medicines contain both THC and CBD.
Sativex, also known as nabiximols, is an oromucosal spray containing these cannabinoids.
NICE recommends a defined trial of THC:CBD spray for selected adults with moderate to severe multiple sclerosis-related spasticity when other pharmacological treatments have not been effective.
This is a specific clinical recommendation, not a general endorsement of cannabis products.
THC, CBD and Chronic Pain
Chronic pain is frequently discussed in cannabinoid research.
However, the evidence does not support unrestricted claims about effectiveness.
NICE guideline NG144 recommends against offering THC, nabilone, dronabinol or THC:CBD combinations for chronic pain in adults.
NICE also recommends against offering CBD for chronic pain outside a clinical trial.
These recommendations illustrate why research findings must be interpreted within their specific clinical context.
Medical Cannabis in the UK
The UK permits certain cannabis-based medicines under defined regulatory and prescribing conditions.
The legal framework distinguishes between medical products and unauthorised recreational cannabis.
Not every product containing THC or CBD qualifies as a medicine.
Readers can explore the broader medical framework in Medical Cannabinoids UK and Medical Cannabis in the UK.
THC vs CBD: UK Legal Status
THC and CBD are treated differently under UK controlled-drug legislation.
THC Under UK Law
Delta-9 THC is a controlled cannabinoid under the Misuse of Drugs Act 1971.
Cannabis is classified as a Class B controlled drug, subject to applicable exemptions and authorisations.
Unauthorised possession, production, supply and importation may constitute offences.
CBD Under UK Law
Pure cannabidiol, as an isolated substance, is not itself controlled under the Misuse of Drugs Act 1971.
However, finished CBD products may contain controlled cannabinoids.
Their legal status depends on composition and applicable exemptions and regulations.
Other regulatory requirements may also apply, including medicines and food law.
Does Hemp Origin Determine Legality?
No. Describing a substance as "hemp-derived" does not automatically establish that a finished product is lawful.
UK legal classification depends on relevant legislation and the actual composition of the product.
Important Legal Distinction
Pure CBD is not itself a controlled drug in the UK, but a product containing controlled cannabinoids may be subject to controlled-drug restrictions.
For authoritative information, consult the Home Office cannabinoid licensing factsheet.
THC vs CBD in Cannabis Oil
The expression "cannabis oil" can describe preparations with very different cannabinoid compositions.
Some products are described as CBD oils, while others may contain THC or combinations of cannabinoids.
The name of a preparation does not establish its medical status, safety or legality.
Learn more in Cannabis Oil UK: Legal and Health Information.
THC vs CBD in Edibles
Cannabis edibles may contain different cannabinoids.
THC-containing edibles can cause intoxication, and their delayed effects can create additional safety concerns.
Products resembling sweets may also create accidental ingestion risks for children.
The legal status of an edible product depends on its composition and relevant UK regulations.
See Are Cannabis Edibles Legal in the UK? for additional context.
Common Misconceptions About THC and CBD
Myth 1: THC and CBD Are the Same Substance
They are distinct chemical compounds with different molecular structures and pharmacological properties.
Myth 2: CBD Has No Side Effects
CBD can cause adverse effects and interact with medicines.
Myth 3: All THC Products Are Medicines
A product containing THC is not automatically an authorised medical treatment.
Myth 4: Natural Cannabinoids Are Always Safe
Naturally occurring substances can have significant biological effects and risks.
Myth 5: CBD Products Are Automatically Legal
Finished products may contain controlled cannabinoids or be subject to additional regulations.
Myth 6: CBD Is Proven to Treat Every Condition
Medical evidence is condition-specific. Broad treatment claims require appropriate clinical evidence.
Myth 7: THC and CBD Always Have Opposite Effects
Their pharmacology is complex, and interactions cannot be reduced to a simple universal opposition.
Myth 8: Online Availability Proves Legality
A product appearing on a website does not establish that its possession or supply is lawful.
Key Takeaway: THC vs CBD
THC and CBD are related cannabinoids, but they differ significantly in their intoxicating properties, effects on the nervous system and legal status.
THC can cause intoxication and is controlled under UK law. Pure CBD is not itself controlled, but finished products require separate legal consideration.
Medical evidence must be evaluated for specific preparations and clinical conditions.
Frequently Asked Questions About THC vs CBD
What is the main difference between THC and CBD?
THC can cause intoxication, while CBD does not typically produce the same intoxicating effects. They also differ in pharmacology and UK legal status.
Are THC and CBD both cannabinoids?
Yes. Both belong to the cannabinoid family of compounds associated with cannabis.
Do THC and CBD have the same molecular formula?
Yes. Both have the molecular formula C21H30O2, but their atoms are arranged differently.
Does CBD cause intoxication?
CBD does not typically cause the THC-like intoxicating effects associated with cannabis.
Is THC legal in the UK?
THC is a controlled cannabinoid. Certain medical and other legal exemptions may apply under defined conditions.
Is CBD legal in the UK?
Pure CBD is not itself controlled, but the legal status of finished CBD products depends on their composition and applicable regulations.
Can THC affect memory?
Yes. THC can impair memory, attention and other cognitive functions.
Can CBD interact with medicines?
Yes. CBD can interact with certain medicines, so professional medical assessment is important.
Are THC and CBD used in prescription medicines?
Certain regulated cannabinoid medicines contain THC, CBD or combinations of the two. Their use depends on specific clinical indications.
Is CBD proven to treat chronic pain?
NICE does not recommend offering CBD for chronic pain in adults outside a clinical trial.
Are THC and CBD safe for teenagers?
THC exposure during adolescence raises particular concerns about brain development and mental health. Prescription cannabinoid medicines for young people require specialist medical oversight.
Does CBD make THC harmless?
No. The presence of CBD does not establish that a THC-containing product is safe or free from impairment risks.
Conclusion: Understanding THC and CBD
THC and CBD are two of the most widely discussed cannabinoids, but their similarities should not obscure their important differences.
THC has established intoxicating effects and can impair cognitive function, coordination and judgement.
CBD does not typically cause THC-like intoxication, although it can have side effects and interact with other medicines.
UK law also distinguishes between THC and pure CBD, while applying additional requirements to finished products.
In medical settings, certain cannabinoid medicines have recognised applications, but evidence varies by medicine and clinical indication.
Accurate information about THC and CBD should therefore distinguish between chemical properties, health effects, scientific evidence and legal classification.